Monty L Evans

Title: **Innovations by Monty L. Evans in Pharmaceutical Formulations**

Introduction

Monty L. Evans is a distinguished inventor based in Johnstown, Ohio, known for his contributions to the field of pharmaceutical formulations. With a portfolio that includes two patents, Evans has made significant strides in creating dosage form units that enhance the delivery of beneficial agents in liquid nutritional products.

Latest Patents

One of Monty L. Evans's latest patents is titled "Sustained release dosage form unit having latex coating and method of making the same." This innovative dosage form unit is designed to deliver one or more beneficial agents, such as a marker dye, into a fluid, notably a liquid enteral nutritional product. The dosage form consists of a core that incorporates a compatible binding agent along with various components like a plasticizer, flow agent, lubricant, and at least one hydrophilic agent. Encased in a latex coating, the core is composed of a hydrophobic base material, ideally formed from cellulose acetate microspheres, which aids in defining a matrix-type membrane. This unique formulation allows for the immediate release of the beneficial agent, ensuring efficiency in nutritional applications.

Career Highlights

Throughout his career, Monty L. Evans has been associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work focuses on innovations that cater to improving health outcomes through advanced formulation technologies.

Collaborations

In his pursuit of innovation, Monty collaborates with notable coworkers, including Terrence B. Mazer and Joseph E. Walton. Together, their combined expertise contributes to the advancement of pharmaceutical products, enhancing the efficacy and delivery mechanisms of beneficial agents.

Conclusion

Monty L. Evans is a prominent figure in the realm of pharmaceutical innovations, with a strong emphasis on developing dosage forms that improve patient care. His patents reflect a commitment to excellence in research and formulation development, thereby impacting the industry positively. As he continues to explore new horizons, Evans remains a vital contributor to scientific advancements in healthcare.